var data={"title":"Virulence determinants of community-acquired methicillin-resistant Staphylococcus aureus","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Virulence determinants of community-acquired methicillin-resistant Staphylococcus aureus</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/contributors\" class=\"contributor contributor_credentials\">Franklin D Lowy, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/contributors\" class=\"contributor contributor_credentials\">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;May 02, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The virulence and rapid transmission of community-acquired methicillin-resistant <em>Staphylococcus aureus</em> (CA-MRSA) infections have raised interest in understanding the pathogenesis of this organism [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/1\" class=\"abstract_t\">1</a>]. The most prevalent strain in the United States, USA300, is now among the most common causes of skin and soft tissue infections in urban emergency departments across the United States [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/2,3\" class=\"abstract_t\">2,3</a>]. Up to 10 percent of these infections are invasive infections such as sepsis, meningitis, osteomyelitis, and necrotizing pneumonia [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/4,5\" class=\"abstract_t\">4,5</a>].</p><p>Issues related to evolution and virulence determinants that appear to be specific to the emergence of these epidemic CA-MRSA clones will be reviewed here. Issues related to the microbiology of MRSA are discussed in detail separately. (See <a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-mrsa-microbiology\" class=\"medical medical_review\">&quot;Methicillin-resistant Staphylococcus aureus (MRSA): Microbiology&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EVOLUTION OF CA-MRSA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Several of the emergent community-acquired methicillin-resistant <em>S. aureus</em> (CA-MRSA) strain sequences demonstrate striking similarity to other clonal MRSA strains [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/6,7\" class=\"abstract_t\">6,7</a>]. The genetic persistence of these strains over time suggests they have core genomic determinants that facilitate their survival and virulence. A limited number of clones are responsible for most MRSA infections. The original methicillin-resistant isolate is strikingly similar in nucleotide sequence to the epidemic strain USA300 [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/6\" class=\"abstract_t\">6</a>]. In addition, the southwest Pacific strain that has caused infections in Australia and other countries in the region is a descendent of the phage <span class=\"nowrap\">80/81</span> strain that has caused outbreaks in newborn nurseries in the 1960s [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/7\" class=\"abstract_t\">7</a>].</p><p>The genetic sequence of USA300 revealed that these strains contained a unique mobile element that includes the methicillin-resistance gene staphylococcal cassette chromosome <em>mec</em> (SCC<em>mec</em>) IVa, the arginine catabolic mobile element, enterotoxins Seq and Sek, and a prophage containing the leukocidin, Panton-Valentine leukocidin [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">VIRULENCE DETERMINANTS AND THEIR REGULATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The enhanced virulence of the community-acquired methicillin-resistant <em>S. aureus</em> (CA-MRSA) strains is not fully understood but appears to result from several contributing factors (<a href=\"image.htm?imageKey=ID%2F69391\" class=\"graphic graphic_figure graphicRef69391 \">figure 1</a>), including:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The presence of the antibiotic resistance gene for methicillin</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The more rapid growth rate of these strains</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Virulence determinants unique to these strains</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Regulatory genes that modulate expression of the virulence determinants</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The host response to infection by these strains</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Factors facilitating transmission and survival of these strains in the environment [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/8,9\" class=\"abstract_t\">8,9</a>]</p><p/><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Panton-Valentine leukocidin</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Panton-Valentine leukocidin (PVL) was among the staphylococcal toxins first described in the 1930s by investigators seeking targets for development of antisera in an era prior to therapeutic antimicrobials [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/10,11\" class=\"abstract_t\">10,11</a>]. These toxins included leukocidins (destructive for phagocytes), hemolysins, necrotoxins (necrotic when injected subcutaneously), and lethal toxin (fatal for rabbits after intravenous injection) [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/10\" class=\"abstract_t\">10</a>].</p><p>PVL is a cytotoxin that causes leukocyte destruction and tissue necrosis; it is encoded by the genes <em>lukS-PV </em>and <em>lukF-PV</em> (together, the two components are referred to as <em>lukSF-PV</em>) [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/12\" class=\"abstract_t\">12</a>]. PVL is often found in strains with mobile genetic elements, SCC<em>mec</em> type IV and V, that carry the methicillin-resistance gene. They are seldom present among SCC<em>mec</em> types I, II, and III (healthcare-associated MRSA strains) [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/13-21\" class=\"abstract_t\">13-21</a>]. Although uncommon, PVL is also present in some methicillin-susceptible strains of <em>S. aureus</em>. PVL-containing <em>S. aureus</em> have been most frequently associated with soft tissue infections and necrotizing pneumonias [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/2,22-27\" class=\"abstract_t\">2,22-27</a>].</p><p>There is a strong epidemiologic association between skin and soft tissue infections and PVL production by the MRSA strain USA300 [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/24\" class=\"abstract_t\">24</a>]. USA300 refers to the strain's pulse field gel electrophoresis pattern; this pattern is the most common among United States MRSA isolates [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/28\" class=\"abstract_t\">28</a>]. In addition, USA300 contains staphylococcal cassette chromosome <em>mec</em> (SCC<em>mec</em>) type IV, which is relatively short (about 20 kb), and, as a result, is capable of rapid horizontal spread among strains of staphylococci.</p><p>Among 320 patients with soft tissue infections presenting to emergency departments in 11 United States cities in 2004, MRSA was the predominant pathogen (78 percent of isolates), and 98 percent of these were USA300 [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/2\" class=\"abstract_t\">2</a>]. Nearly all of the USA300 isolates contained SCC<em>mec</em> type IV and the <em>lukSF-PV</em> genes encoding PVL, whereas genes for common staphylococcal enterotoxins and toxic shock syndrome were seldom present. Subsequently, both MRSA and methicillin-susceptible <em>S. aureus</em> (MSSA) USA300 PVL-positive strains were noted among 843 patients admitted to a large public hospital in Los Angeles in 2005, but there were no reliable epidemiologic factors to distinguish those with CA-MRSA from those with CA-MSSA [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/29\" class=\"abstract_t\">29</a>]. (See <a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-mrsa-in-adults-epidemiology\" class=\"medical medical_review\">&quot;Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Epidemiology&quot;</a>.)</p><p>Inevitably, MRSA isolates elaborating PVL have also spread to hospitalized patients causing nosocomial infections. Among 37 clinical MRSA isolates at a veterans hospital, for example, 60 percent were USA300 PVL positive [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/30\" class=\"abstract_t\">30</a>]. The strain has also spread to several countries on various continents [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/14,31\" class=\"abstract_t\">14,31</a>].</p><p>Although PVL has a strong epidemiologic association with CA-MRSA infections, its role in the pathogenesis and spread of infection is controversial [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/15,32-36\" class=\"abstract_t\">15,32-36</a>]. The most compelling clinical data have been the association of PVL with necrotizing pneumonia, particularly in the setting of post-influenza respiratory infections [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/17,18\" class=\"abstract_t\">17,18</a>]. A rabbit model of necrotizing pneumonia demonstrated that PVL plays a critical role in infection [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/37\" class=\"abstract_t\">37</a>]. The authors hypothesized that, in the presence of a sufficient number of bacteria, PVL is produced, resulting in the activation of polymorphonuclear leukocytes (PMNs) and macrophages with the consequent release of inflammatory cytokines. In addition, the PVL lyses PMNs, causing the release of granules and proteolytic enzymes.</p><p>In other settings, the presence of PVL may not be as important. Among 109 patients with MRSA hospital-acquired pneumonia and ventilator-acquired pneumonia (including PVL+ strains in 27 percent of cases), the severity of disease and clinical outcome was not influenced by the presence of the PVL gene [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/38\" class=\"abstract_t\">38</a>]. The PVL gene may be variably expressed in different settings. This was illustrated in an analysis of 31 <em>S. aureus</em> strains collected from patients with infections of varying severity; the quantity of PVL produced in vitro did not correlate with severity of infection [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/36\" class=\"abstract_t\">36</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Alpha-hemolysin</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Alpha-hemolysin is a well-characterized toxin capable of forming pores in selected host cells, including erythrocytes, macrophages, and lymphocytes; it appears to play a critical role in the pathogenesis of infection in a mouse model [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/39\" class=\"abstract_t\">39</a>]. In mice infected with isogenic strains of USA300, alpha-hemolysin was essential for development of pneumonia, but PVL was not [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/34\" class=\"abstract_t\">34</a>]. Subsequent studies demonstrated vaccination with the toxin protected mice from infection [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/40\" class=\"abstract_t\">40</a>]. More recently, studies using rabbit models of pneumonia and also of skin and soft tissue infections have also demonstrated the important role of alpha-toxin in the pathogenesis of these infections as well as the ability anti-alpha-toxin antibodies to protect against these infections [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/41,42\" class=\"abstract_t\">41,42</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Phenol soluble modulins (PSMs)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>PSMs are small cytolytic peptides that are secreted in greater quantities by CA-MRSA than traditional isolates. These peptides are capable of attracting and lysing polymorphonuclear leukocytes, have proinflammatory effects, and impair the host defense against staphylococcal infection [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/43\" class=\"abstract_t\">43</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Arginine catabolic mobile element (ACME)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>ACME is a pathogenicity island identified in USA300; it is rarely found in other strains of <em>S. aureus</em>, and its role in virulence is still uncertain [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/44\" class=\"abstract_t\">44</a>]. ACME is usually linked to SCC<em>mec</em> and inserts into the same region, <em>orfX</em>. The gene cluster in ACME consists of <em>arc</em> and <em>opp-3</em>. The <em>arc</em> gene encodes the arginine deiminase system; depletion of arginine may reduce nitric oxide production. ACME facilitates staphylococcal survival in acidic environments and, as a result, may enhance its ability to survive on skin surfaces [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/45,46\" class=\"abstract_t\">45,46</a>]. The presence of <em>SpeG</em>, a gene that detoxifies polyamines that are found in the skin, may increase bacterial burden in abscesses [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/46,47\" class=\"abstract_t\">46,47</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Accessory gene regulator</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The accessory gene regulator (<em>agr</em>) is a regulatory gene in <em>S. aureus</em> that can control expression of virulent genes [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/48,49\" class=\"abstract_t\">48,49</a>]. <em>agr</em> has several polymorphisms (I to IV), and strains can be grouped based on these polymorphisms. In one study of CA-MRSA virulence in a rat pneumonia model using USA300 and USA400 strains, higher levels of regulatory genes including <em>agr</em> were produced by USA300 in vitro, suggesting one potential mechanism for its apparent enhanced virulence [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/50\" class=\"abstract_t\">50</a>].</p><p>The role of <em>agr</em> and other regulatory genes in CA-MRSA infections is not fully understood; however, in the CA-MRSA strain, USA300 <em>agr</em> appears to enhance expression of surface adhesins, toxins, and exoenzymes, all of which may contribute to enhanced virulence [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/51\" class=\"abstract_t\">51</a>].</p><p class=\"headingAnchor\" id=\"H7775513\"><span class=\"h2\">Serologic response to infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In one study including 235 children with <em>S. aureus</em> colonization, those with invasive staphylococcal infections had the lowest alpha-hemolysin and Panton-Valentine leukocidin (LukF and LukS subunits) antibody titers; those with cutaneous <em>S. aureus</em> infection did not achieve a lasting immune response following infection. Patients with higher convalescent alpha-hemolysin antibody titers had longer duration of protection against recurrent infection over one year [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/52\" class=\"abstract_t\">52</a>].</p><p class=\"headingAnchor\" id=\"H991050596\"><span class=\"h2\">Transmission and survival in the environment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The CA-MRSA epidemic clones may be more efficient than other strains at colonizing multiple body sites and surviving on environmental surfaces [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/53-56\" class=\"abstract_t\">53-56</a>]. These factors may contribute to an enhanced risk of reinfections in community reservoirs [<a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/57\" class=\"abstract_t\">57</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>USA300 is the most prevalent strain of methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) and is among the most common causes of skin and soft tissue infections in the United States and other countries. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The virulence and rapid transmission of community-acquired (CA-)MRSA have raised interest in understanding the pathogenesis of this organism. The enhanced virulence of the CA-MRSA strains is not fully understood but appears to result from several contributing factors. (See <a href=\"#H3\" class=\"local\">'Virulence determinants and their regulation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Several of the emergent CA-MRSA strain sequences demonstrate striking similarity to other clonal MRSA strains. The genetic persistence of these strains over time suggests they have core genomic determinants that facilitate their survival and virulence. (See <a href=\"#H2\" class=\"local\">'Evolution of CA-MRSA'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bacterial virulence determinants include Panton-Valentine leukocidin (PVL), alpha-hemolysin, phenol soluble modulins (PSMs), and arginine catabolic mobile element (ACME). The accessory gene regulator (<em>agr</em>) is a regulatory gene in <em>S. aureus</em> that can control expression of virulent genes. (See <a href=\"#H3\" class=\"local\">'Virulence determinants and their regulation'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/1\" class=\"nounderline abstract_t\">Morrison MA, Hageman JC, Klevens RM. Case definition for community-associated methicillin-resistant Staphylococcus aureus. J Hosp Infect 2006; 62:241.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/2\" class=\"nounderline abstract_t\">Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/3\" class=\"nounderline abstract_t\">Talan DA, Krishnadasan A, Gorwitz RJ, et al. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis 2011; 53:144.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/4\" class=\"nounderline abstract_t\">Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352:1436.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/5\" class=\"nounderline abstract_t\">Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368:874.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/6\" class=\"nounderline abstract_t\">Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006; 367:731.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/7\" class=\"nounderline abstract_t\">Robinson DA, Kearns AM, Holmes A, et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 2005; 365:1256.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/8\" class=\"nounderline abstract_t\">Diep BA, Otto M. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol 2008; 16:361.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/9\" class=\"nounderline abstract_t\">Lowy FD. Secrets of a superbug. Nat Med 2007; 13:1418.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/10\" class=\"nounderline abstract_t\">Panton PN, Valentine FCO. Staphylococcal toxin. Lancet 1932; 1:506.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/11\" class=\"nounderline abstract_t\">Panton PN, Valentine FCO, Dix VW. Staphylococcal infection and antitoxin treatment. Lancet 1931; 2:1180.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/12\" class=\"nounderline abstract_t\">John JF Jr, Lindsay JA. Clones and drones: do variants of Panton-Valentine leukocidin extend the reach of community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis 2008; 197:175.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/13\" class=\"nounderline abstract_t\">Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290:2976.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/14\" class=\"nounderline abstract_t\">Larsen AR, B&ouml;cher S, Stegger M, et al. Epidemiology of European community-associated methicillin-resistant Staphylococcus aureus clonal complex 80 type IV strains isolated in Denmark from 1993 to 2004. J Clin Microbiol 2008; 46:62.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/15\" class=\"nounderline abstract_t\">Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest 2007; 87:3.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/16\" class=\"nounderline abstract_t\">Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359:753.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/17\" class=\"nounderline abstract_t\">Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005; 40:100.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/18\" class=\"nounderline abstract_t\">Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006; 12:894.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/19\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56:325.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/20\" class=\"nounderline abstract_t\">Wiese-Posselt M, Heuck D, Draeger A, et al. Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005. Clin Infect Dis 2007; 44:e88.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/21\" class=\"nounderline abstract_t\">Sola C, Saka HA, Vindel A, et al. High frequency of Panton-Valentine leukocidin genes in invasive methicillin-susceptible Staphylococcus aureus strains and the relationship with methicillin-resistant Staphylococcus aureus in C&oacute;rdoba, Argentina. Eur J Clin Microbiol Infect Dis 2007; 26:281.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/22\" class=\"nounderline abstract_t\">Aires-de-Sousa M, Concei&ccedil;&atilde;o T, de Lencastre H. Unusually high prevalence of nosocomial Panton-Valentine leukocidin-positive Staphylococcus aureus isolates in Cape Verde Islands. J Clin Microbiol 2006; 44:3790.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/23\" class=\"nounderline abstract_t\">Bocchini CE, Hulten KG, Mason EO Jr, et al. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 2006; 117:433.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/24\" class=\"nounderline abstract_t\">Davis SL, Perri MB, Donabedian SM, et al. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 2007; 45:1705.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/25\" class=\"nounderline abstract_t\">Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315:1130.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/26\" class=\"nounderline abstract_t\">Lina G, Pi&eacute;mont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29:1128.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/27\" class=\"nounderline abstract_t\">Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 2007; 45:315.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/28\" class=\"nounderline abstract_t\">McDougal LK, Steward CD, Killgore GE, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003; 41:5113.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/29\" class=\"nounderline abstract_t\">Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/30\" class=\"nounderline abstract_t\">Gonzalez BE, Rueda AM, Shelburne SA 3rd, et al. Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 2006; 27:1051.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/31\" class=\"nounderline abstract_t\">Tristan A, Bes M, Meugnier H, et al. Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007; 13:594.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/32\" class=\"nounderline abstract_t\">Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194:1761.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/33\" class=\"nounderline abstract_t\">Zhang K, McClure JA, Elsayed S, et al. Coexistence of Panton-Valentine leukocidin-positive and -negative community-associated methicillin-resistant Staphylococcus aureus USA400 sibling strains in a large Canadian health-care region. J Infect Dis 2008; 197:195.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/34\" class=\"nounderline abstract_t\">Bubeck Wardenburg J, Bae T, Otto M, et al. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007; 13:1405.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/35\" class=\"nounderline abstract_t\">Diep BA, Sensabaugh GF, Somboonna N, et al. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 2004; 42:2080.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/36\" class=\"nounderline abstract_t\">Hamilton SM, Bryant AE, Carroll KC, et al. In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections. Clin Infect Dis 2007; 45:1550.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/37\" class=\"nounderline abstract_t\">Diep BA, Chan L, Tattevin P, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A 2010; 107:5587.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/38\" class=\"nounderline abstract_t\">Peyrani P, Allen M, Wiemken TL, et al. Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene. Clin Infect Dis 2011; 53:766.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/39\" class=\"nounderline abstract_t\">Berube BJ, Bubeck Wardenburg J. Staphylococcus aureus &alpha;-toxin: nearly a century of intrigue. Toxins (Basel) 2013; 5:1140.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/40\" class=\"nounderline abstract_t\">Bubeck Wardenburg J, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 2008; 205:287.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/41\" class=\"nounderline abstract_t\">Diep BA, Le VT, Badiou C, et al. IVIG-mediated protection against necrotizing pneumonia caused by MRSA. Sci Transl Med 2016; 8:357ra124.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/42\" class=\"nounderline abstract_t\">Le VT, Tkaczyk C, Chau S, et al. Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections. Antimicrob Agents Chemother 2016; 60:5640.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/43\" class=\"nounderline abstract_t\">Wang R, Braughton KR, Kretschmer D, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007; 13:1510.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/44\" class=\"nounderline abstract_t\">Diep BA, Stone GG, Basuino L, et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 2008; 197:1523.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/45\" class=\"nounderline abstract_t\">Montgomery CP, Boyle-Vavra S, Daum RS. The arginine catabolic mobile element is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus USA300 genetic background. Infect Immun 2009; 77:2650.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/46\" class=\"nounderline abstract_t\">Thurlow LR, Joshi GS, Clark JR, et al. Functional modularity of the arginine catabolic mobile element contributes to the success of USA300 methicillin-resistant Staphylococcus aureus. Cell Host Microbe 2013; 13:100.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/47\" class=\"nounderline abstract_t\">Joshi GS, Spontak JS, Klapper DG, Richardson AR. Arginine catabolic mobile element encoded speG abrogates the unique hypersensitivity of Staphylococcus aureus to exogenous polyamines. Mol Microbiol 2011; 82:9.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/48\" class=\"nounderline abstract_t\">Cheung AL, Eberhardt KJ, Chung E, et al. Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest 1994; 94:1815.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/49\" class=\"nounderline abstract_t\">Novick RP, Geisinger E. Quorum sensing in staphylococci. Annu Rev Genet 2008; 42:541.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/50\" class=\"nounderline abstract_t\">Montgomery CP, Boyle-Vavra S, Adem PV, et al. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 2008; 198:561.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/51\" class=\"nounderline abstract_t\">Cheung GY, Wang R, Khan BA, et al. Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect Immun 2011; 79:1927.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/52\" class=\"nounderline abstract_t\">Fritz SA, Tiemann KM, Hogan PG, et al. A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection. Clin Infect Dis 2013; 56:1554.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/53\" class=\"nounderline abstract_t\">Miller LG, Diep BA. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46:752.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/54\" class=\"nounderline abstract_t\">Yang ES, Tan J, Eells S, et al. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect 2010; 16:425.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/55\" class=\"nounderline abstract_t\">Desai R, Pannaraj PS, Agopian J, et al. Survival and transmission of community-associated methicillin-resistant Staphylococcus aureus from fomites. Am J Infect Control 2011; 39:219.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/56\" class=\"nounderline abstract_t\">Knox J, Uhlemann AC, Lowy FD. Staphylococcus aureus infections: transmission within households and the community. Trends Microbiol 2015; 23:437.</a></li><li><a href=\"https://www.uptodate.com/contents/virulence-determinants-of-community-acquired-methicillin-resistant-staphylococcus-aureus/abstract/57\" class=\"nounderline abstract_t\">Uhlemann AC, Knox J, Miller M, et al. The environment as an unrecognized reservoir for community-associated methicillin resistant Staphylococcus aureus USA300: a case-control study. PLoS One 2011; 6:e22407.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3152 Version 12.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H9\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EVOLUTION OF CA-MRSA</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">VIRULENCE DETERMINANTS AND THEIR REGULATION</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Panton-Valentine leukocidin</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Alpha-hemolysin</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Phenol soluble modulins (PSMs)</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Arginine catabolic mobile element (ACME)</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Accessory gene regulator</a></li><li><a href=\"#H7775513\" id=\"outline-link-H7775513\">Serologic response to infection</a></li><li><a href=\"#H991050596\" id=\"outline-link-H991050596\">Transmission and survival in the environment</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/3152|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/69391\" class=\"graphic graphic_figure\">- CA-MRSA virulence factors</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-mrsa-in-adults-epidemiology\" class=\"medical medical_review\">Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Epidemiology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-mrsa-microbiology\" class=\"medical medical_review\">Methicillin-resistant Staphylococcus aureus (MRSA): Microbiology</a></li></ul></div></div>","javascript":null}